Abstract
Background and
Aim of Study:
The COVID-19 pandemic has posed an unprecedented threat to global
healthcare delivery. Moewardi Hospital was appointed by the government of
Indonesia to be a COVID-19 one of regional hospital by June 2020. Other than
COVID-19 cases, the hospital also provides care for other diseases which also
provides care for oncology patients.
The aim of the study: to assess the impact of the social restriction on oncology
services in this hospital.
Material and Methods: This study compares the number of patients undergoing oncology surgery in the
Central Surgery Unit and the number of patients attending the Outpatient Surgical
Oncology Unit in March to July 2020 with the number of patients in the same
timeframe in the previous year (2019).
Results: The number of oncology operations in the Central Surgery Unit of Moewardi
Hospital declined substantially during the 5-month pandemic period compared to
the same period in the previous year, 2019 (p<0>significant drop in the number of patients attending the outpatient surgical
oncology clinic during the pandemic period compared to the previous year
(p<0>which was 20 patients. The lowest number of patients visited was 170 outpatients
in March 2020. Thyroid and skin cancer cases were the most notable decline in
surgical oncology cases in the Central Surgery Unit. The largest number of
outpatients in the outpatient surgical oncology clinic during the COVID-19
pandemic was mammae and thyroid cancer.
Conclusions: There was a decline in surgical oncology activities, which culminated in a
significant decrease in surgical oncology patients in the Central Surgery Unit and
the patient visit to the Moewardi Hospital outpatient oncology clinic during the
COVID-19 pandemic.
